Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis

BACKGROUND: Adjuvant radiotherapy in advanced head and neck squamous cell cancer (HNSCC) reduces the risk of local-regional failure and most likely increases the survival rate. Patients at high risk for tumor recurrence may benefit from more aggressive altered fractionation schedules in order to red...

Descripción completa

Detalles Bibliográficos
Autores principales: Matuschek, Christiane, Haussmann, Jan, Bölke, Edwin, Gripp, Stephan, Schuler, Patrick J., Tamaskovics, Bálint, Gerber, Peter Arne, Djiepmo-Njanang, Freddy-Joel, Kammers, Kai, Plettenberg, Christian, Anooshahr, Bahar, Orth, Klaus, Budach, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172789/
https://www.ncbi.nlm.nih.gov/pubmed/30286777
http://dx.doi.org/10.1186/s13014-018-1133-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172789/
https://www.ncbi.nlm.nih.gov/pubmed/30286777
http://dx.doi.org/10.1186/s13014-018-1133-8

Ejemplares similares